Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Biomedicines
|
July 28, 2018
Progress in Adenoviral Capsid-Display Vaccines
Marija Vujadinovic, Jort Vellinga
The Journal of General Virology
|
May 26, 2005
The adenovirus capsid: major progress in minor proteins
Jort Vellinga, Stephanie Van der Heijdt, Rob C Hoeben
Endocrinology
|
January 25, 2005
The p38 mitogen-activated protein kinase inhibitor SB203580 reduces glucose turnover by the glucose transporter-4 of 3T3-L1 adipocytes in the insulin-stimulated state
Merlijn Bazuine, Françoise Carlotti, Martijn J W E Rabelink, et al.
The Journal of Gene Medicine
|
November 17, 2005
A system for efficient generation of adenovirus protein IX-producing helper cell lines
Jort Vellinga, Taco G Uil, Jeroen de Vrij, et al.
Journal of Virology
|
October 19, 2018
αvβ3 Integrin Is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26
Davor Nestić, Taco G Uil, Jiangtao Ma, et al.
The Journal of General Virology
|
April 26, 2014
An alternative to the adenovirus inverted terminal repeat sequence increases the viral genome replication rate and provides a selective advantage in vitro
Kerstin Wunderlich, Esmeralda van der Helm, Dirk Spek, et al.
Vaccine
|
August 31, 2015
Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats
Myra N Widjojoatmodjo, Lies Bogaert, Bob Meek, et al.
Journal of Virology
|
February 15, 2005
The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability
Jort Vellinga, Diana J M van den Wollenberg, Stephanie van der Heijdt, et al.
International Journal of Cancer
|
November 22, 2017
Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8<sup>+</sup> T cell responses against HPV16 oncoproteins
Nicolas Çuburu, Selina Khan, Cynthia D Thompson, et al.
Human Gene Therapy
|
March 6, 2014
Challenges in manufacturing adenoviral vectors for global vaccine product deployment
Jort Vellinga, J Patrick Smith, Agnieszka Lipiec, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Biomedicines
|
July 28, 2018
Progress in Adenoviral Capsid-Display Vaccines
Marija Vujadinovic, Jort Vellinga
The Journal of General Virology
|
May 26, 2005
The adenovirus capsid: major progress in minor proteins
Jort Vellinga, Stephanie Van der Heijdt, Rob C Hoeben
Endocrinology
|
January 25, 2005
The p38 mitogen-activated protein kinase inhibitor SB203580 reduces glucose turnover by the glucose transporter-4 of 3T3-L1 adipocytes in the insulin-stimulated state
Merlijn Bazuine, Françoise Carlotti, Martijn J W E Rabelink, et al.
The Journal of Gene Medicine
|
November 17, 2005
A system for efficient generation of adenovirus protein IX-producing helper cell lines
Jort Vellinga, Taco G Uil, Jeroen de Vrij, et al.
Journal of Virology
|
October 19, 2018
αvβ3 Integrin Is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26
Davor Nestić, Taco G Uil, Jiangtao Ma, et al.
The Journal of General Virology
|
April 26, 2014
An alternative to the adenovirus inverted terminal repeat sequence increases the viral genome replication rate and provides a selective advantage in vitro
Kerstin Wunderlich, Esmeralda van der Helm, Dirk Spek, et al.
Vaccine
|
August 31, 2015
Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats
Myra N Widjojoatmodjo, Lies Bogaert, Bob Meek, et al.
Journal of Virology
|
February 15, 2005
The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability
Jort Vellinga, Diana J M van den Wollenberg, Stephanie van der Heijdt, et al.
International Journal of Cancer
|
November 22, 2017
Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8<sup>+</sup> T cell responses against HPV16 oncoproteins
Nicolas Çuburu, Selina Khan, Cynthia D Thompson, et al.
Human Gene Therapy
|
March 6, 2014
Challenges in manufacturing adenoviral vectors for global vaccine product deployment
Jort Vellinga, J Patrick Smith, Agnieszka Lipiec, et al.
Page
of 3